Selank dosage

Selank intranasal dosage

Reported intranasal protocols use 250–400 mcg per day, divided across 1-2 administrations daily for 2-6 weeks.[1][2][3]

Selank is a tuftsin-derived peptide associated with anxiety and stress-response signaling. Nasal concentration and the volume delivered per application determine the actual amount.[2][3][4]

Selank injectable dosage

Reported-use amounts for Selank are ~250 mcg per administration, daily, for 2–6 wk. A reported subcutaneous progression uses 300 mcg once daily for weeks 1–2 and 500 mcg once daily for weeks 3–4, followed by four weeks off. This four-week-on/four-week-off pattern is not a nasal formulation schedule.[10][11]

Injectable Selank is a separate preparation of the tuftsin-derived peptide. Nasal concentration and delivered spray volume do not define its injection amount.[2][3][4][10]

Frequency and timing

Afternoon or evening is the listed timing for the nasal and injection patterns.[1][2][3][10]

Cycle length and breaks

Intranasal: 2-6 weeks. Injectable: 2–6 wk. A separate reported subcutaneous cycle pattern uses four weeks on followed by four weeks off; nasal schedules differ.[1][2][3][10][11]

Approval and product quality

Selank is not an FDA-approved drug.[1][7][8][9]

Side effects and long-term safety

Nasal irritation, fatigue, headache and calm or sedating effects are practical tolerability concerns. Long-term intranasal use, medication interactions, pregnancy and pediatric safety remain poorly characterized.[2][3][4][5]

Route-specific dosing limits

Medication overlap, psychiatric context, and formulation quality drive the cautions. Reported-use injectable schedules and additional protocol patterns are not established human treatment regimens or approved product instructions.[2][3][4][5][11][10]